21 May 2013
Keywords: avi, pharma, ercole, mrna, accord, biopharma, fellow
Article | 22 December 2006
AVI BioPharma and fellow USA-based Ercole Biotech have entered into a cross-license and collaboration agreement to identify and develop drugs
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2006
20 May 2013
© 2013 thepharmaletter.com